摘要
L-肉毒碱可减轻乳腺癌辅助治疗药物他莫昔芬的不良反应,降低肿瘤复发和转移风险,改善预后。本文简要综述相关临床应用研究进展。
Tamoxifen is widely used in the treatment of breast cancer. However, serious adverse drug reactions （ADRs） limit its clinical use. L-carnitine can reduce tamoxifen ADRs and cancer recurrence risk and improve cancer prognosis. As a result, L-camitine can be used as tamoxifen endocrine adjuvant therapy for the treatment of breast cancer. This review describes the application of L-carnitine into prevention from tamoxifen ADRs in breast cancer treatment.
出处
《世界临床药物》
CAS
2015年第8期573-576,共4页
World Clinical Drug
关键词
乳腺癌
L-肉毒碱
他莫昔芬
不良反应
breast cancer
L-carnitine
tamoxifen
adverse drug reaction
